National Association of Testing Authorities, Australia
Scope of Accreditation
Douglass Hanly Moir Pathology
Site
SAN Pathology, A subsidiary of Douglass Hanly Moir Pty Ltd
Accreditation No.
2178
Site No.
22740
Date of Accreditation
16 Dec 2014
Address
Level 5, Clifford Building, Sydney Adventist Hospital, 185 Fox Valley Road
Wahroonga, NSW 2076
Australia
Contact
Availability
Services available to external clients
Supervision
GY (General)
Scope of Accreditation
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
01 Jun 2029
Last Activity Date
05 Jun 2024
Service | Product | Determinant |
---|---|---|
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Other body fluids; Sputum; Urine | Cytological examination; Review and reporting of cytology samples |
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination |
Anatomical pathology - Tissue pathology - Examination of biopsy materialReporting only. | Formalin fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
Anatomical pathology - Tissue pathology - Gene probes using paraffin in-situ hybridisation techniques (chromogenic/silver)Reporting only. | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue; Tissue imprint | Intra-operative consultation and examination of biopsy material |
Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigationReporting only | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2029
Last Activity Date
05 Jun 2024
Service | Product | Determinant |
---|---|---|
Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Blood; Swabs; Urine | Snake venom detection |
Plasma; Serum | Ethanol; Paracetamol (acetaminophen); Salicylate | |
Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Vancomycin |
Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | Prostate specific antigen (PSA) |
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Parathyroid hormone (PTH) |
Serum | Cortisol | |
Chemical pathology - Further investigation of cardiac function | Plasma; Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP); Troponin I |
Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation; Lipoprotein subclasses |
Lipoprotein subclasses | ||
Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
Plasma; Serum | Haptoglobins | |
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total |
Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Osmolality; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; Uric acid; γ-Glutamyltransferase | |
Plasma; Serum; Urine | Osmolality | |
Urine | Creatinine; Potassium; Protein - Total; Sodium | |
Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin |
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma | Amino acids |
Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2029
Last Activity Date
05 Jun 2024
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Creatinine; Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2029
Last Activity Date
05 Jun 2024
Service | Product | Determinant |
---|---|---|
Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
Haematology - Examination of blood films by special staining | Blood | Malaria |
Haematology - Full blood examination | Blood | Differential number; Morphology |
Differential number; Erythrocyte count (red blood cell count, RBCC); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes | ||
Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Activated partial thromboplastin time (APTT); Anti-Xa - Apixaban; Anti-Xa - Dabigatran; Anti-Xa - Rivaroxaban; Anti-Xa activity - Clexane - Low molecular weight heparin; Anti-Xa activity - Unfractionated heparin; D-dimer; Fibrinogen; International normalised ratio (INR); Prothrombin time (PT) |
Activated partial thromboplastin time (APTT); International normalised ratio (INR); Prothrombin time (PT) | ||
Serum | Heparin induced thrombotic thrombocytopenia (HITT) | |
Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
Immunohaematology - Blood group antibody detection | Blood | Other blood group systems; Rh phenotypes |
Immunohaematology - Blood grouping | Blood | ABO; RhD |
Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody titration; Other blood group antibodies; Red blood cell phenotyping; Rh |
Antibody elution | ||
Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Compliance with transport, storage and distribution requirements of blood, products and components |
Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2029
Last Activity Date
05 Jun 2024
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2029
Last Activity Date
05 Jun 2024
Service | Product | Determinant |
---|---|---|
Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
Microbiology - Bacteriology - Detection of pathogenic bacteria | Cerebrospinal fluid (CSF); Fluids; Genital specimens; Nasal swabs; Synovial fluid; Tissues; Wound swabs | Bacteria; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) |
Urine | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Red blood cell morphology | |
Legionella longbeachae antigen; Legionella pneumophila antigen; Streptococcus pneumoniae antigen | ||
Blood; Glucose; Ketones; Proteins; Specific gravity; pH | ||
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Combined nose and throat swabs; Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) A/B | |
Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF) | Cryptococcus antigen |
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2029
Last Activity Date
05 Jun 2024
Service | Product | Determinant |
---|---|---|
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2178
Site No.
22740
Print date
10 Oct 2024